文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

美国国立综合癌症网络（NCCN）指南解读：肝胆癌，2017年第1版

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

作者信息

Benson Al B, D'Angelica Michael I, Abbott Daniel E, Abrams Thomas A, Alberts Steven R, Saenz Daniel Anaya, Are Chandrakanth, Brown Daniel B, Chang Daniel T, Covey Anne M, Hawkins William, Iyer Renuka, Jacob Rojymon, Karachristos Andrea, Kelley R Kate, Kim Robin, Palta Manisha, Park James O, Sahai Vaibhav, Schefter Tracey, Schmidt Carl, Sicklick Jason K, Singh Gagandeep, Sohal Davendra, Stein Stacey, Tian G Gary, Vauthey Jean-Nicolas, Venook Alan P, Zhu Andrew X, Hoffmann Karin G, Darlow Susan

机构信息

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Memorial Sloan Kettering Cancer Center

出版信息

J Natl Compr Canc Netw. 2017 May;15(5):563-573. doi: 10.6004/jnccn.2017.0059.

DOI:10.6004/jnccn.2017.0059
PMID:28476736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5557008/
Abstract

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

摘要

美国国立综合癌症网络（NCCN）肝胆癌临床实践指南为肝癌、胆囊癌和胆管癌提供治疗建议。NCCN肝胆癌专家小组至少每年召开一次会议，以审查其所在机构评审人员的意见，研究出版物和摘要中的相关新数据，并重新评估和更新其建议。这些NCCN指南见解总结了该专家小组关于肝细胞癌患者局部区域治疗的讨论和最新建议。

相似文献

[1]
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

J Natl Compr Canc Netw. 2017-5

[2]
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

J Natl Compr Canc Netw. 2019-4-1

[3]
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

J Natl Compr Canc Netw. 2022-3

[4]
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

J Natl Compr Canc Netw. 2023-1

[5]
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

J Natl Compr Canc Netw. 2017-1

[6]
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.

J Natl Compr Canc Netw. 2023-7

[7]
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw. 2013-5-1

[8]
Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.

J Natl Compr Canc Netw. 2010-7

[9]
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

J Natl Compr Canc Netw. 2018-3

[10]
Rectal Cancer, Version 2.2015.

J Natl Compr Canc Netw. 2015-6

引用本文的文献

[1]
Early prediction of proton therapy dose distributions and DVHs for hepatocellular carcinoma using contour-based CNN models from diagnostic CT and MRI.

Radiat Oncol. 2025-8-4

[2]
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: Review and bibliometric.

ILIVER. 2024-2-6

[3]
Establishment of a prognostic nomogram and risk stratification system for patients with distant-metastatic hepatocellular carcinoma: A population-based study.

Medicine (Baltimore). 2025-6-13

[4]
Hepatocellular carcinoma cell-derived small extracellular vesicle-associated CD147 serves as a diagnostic marker and promotes endothelial cell angiogenesis via the PI3K/Akt pathway.

Extracell Vesicles Circ Nucl Acids. 2023-10-12

[5]
Application of immunofluorescence-based detection of AFP-L3 in the diagnosis of hepatocellular carcinoma.

Medicine (Baltimore). 2025-4-18

[6]
Advances in radiation therapy for HCC: Integration with liver-directed treatments.

Hepatol Commun. 2025-3-21

[7]
Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.

PLoS One. 2025-3-10

[8]
Management of advanced gallbladder adenocarcinoma: A case report and review of treatment strategies.

Int J Surg Case Rep. 2025-2

[9]
Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study.

Cancer Med. 2024-12

[10]
Machine learning based on alcohol drinking-gut microbiota-liver axis in predicting the occurrence of early-stage hepatocellular carcinoma.

BMC Cancer. 2024-11-29

本文引用的文献

[1]
Local ablative treatments for hepatocellular carcinoma: An updated review.

World J Gastrointest Pharmacol Ther. 2016-11-6

[2]
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis.

Int J Radiat Oncol Biol Phys. 2016-2-13

[3]
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Cancer. 2016-5-1

[4]
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.

Cochrane Database Syst Rev. 2016-2-16

[5]
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

J Clin Oncol. 2016-6-10

[6]
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

J Hepatol. 2016-1-22

[7]
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

J Clin Oncol. 2016-2-10

[8]
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

J Clin Oncol. 2016-2-10

[9]
Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect?

Radiology. 2015-9

[10]
Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Radiother Oncol. 2014-12-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索